The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20072051
The Journal of Experimental Medicine, Vol. 205, No. 4, 967-979
The Rockefeller University Press, 0022-1007 $30.00
© Hill et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3318K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, J. A.
Right arrow Articles by Cairns, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, J. A.
Right arrow Articles by Cairns, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice

Jonathan A. Hill1, David A. Bell1,2,3, William Brintnell1,2, David Yue1, Bret Wehrli4, Anthony M. Jevnikar1,2,5, David M. Lee6, Wolfgang Hueber7,8, William H. Robinson7,8, and Ewa Cairns1,2

1 Department of Microbiology and Immunology and 2 Department of Medicine, University of Western Ontario, London, Ontario, Canada, N6A 5C1
3 Division of Rheumatology, 4 Department of Pathology, and 5 Division of Nephrology, London Health Sciences Centre, London, Ontario, Canada, N6A 5A5
6 Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA 02215
7 Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA 94305
8 Veterans Affairs Palo Alto Health Care System, Geriatric Research Education and Clinical Centers, Palo Alto, CA 94304

CORRESPONDENCE Ewa Cairns: ecairns{at}uwo.ca

Rheumatoid arthritis (RA) is a common autoimmune disease that afflicts the synovium of diarthrodial joints. The pathogenic mechanisms inciting this disease are not fully characterized, but may involve the loss of tolerance to posttranslationally modified (citrullinated) antigens. We have demonstrated that this modification leads to a selective increase in antigenic peptide affinity for major histocompatibility complex (MHC) class II molecules that carry the RA-associated shared epitope, such as HLA-DRB1*0401 (DR4). We describe the induction of arthritis in DR4-IE transgenic (tg) mice with citrullinated fibrinogen, a protein commonly found in inflamed synovial tissue and a frequent target of autoantibodies in RA patients. The disease induced in these mice was characterized by synovial hyperplasia followed by ankylosis, but lacked a conspicuous polymorphonuclear cell infiltrate. Immunological analysis of these mice through T cell epitope scanning and antibody microarray analysis identified a unique profile of citrulline-specific reactivity that was not found in DR4-IE tg mice immunized with unmodified fibrinogen or in wild-type C57BL/6 mice immunized with citrullinated fibrinogen, two conditions where arthritis was not observed. These observations directly implicate citrullinated fibrinogen as arthritogenic in the context of RA-associated MHC class II molecules.


Abbreviations used: AMC, anti-modified citrulline; CithFib, citrullinated hFib; CitmFib, citrullinated mFib; DR4-IE tg, HLA-DRB1*0401 tg; HE, hematoxylin and eosin; hFib, human fibrinogen; mFib, mouse fibrinogen; RA, rheumatoid arthritis; SE, shared epitope; tg, transgenic.

J.A. Hill's present address is Section on Immunology and Immunogenetics, Joslin Diabetes Center, Boston, MA 02215.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS